Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis

Mimura, Takeshi; Rizzello, F; Helwig, U; Poggioli, G; Schreiber, S; C Talbot, I; J Nicholls, R; Gionchetti, P; Campieri, M; A Kamm, M

doi:10.1136/gut.53.1.108

Public

Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis

Published in Gut • Dec 18, 2003

Authors:

Takeshi Mimura

F Rizzello

U Helwig

Abstract

BACKGROUND: Ten to 15% of patients with pouchitis experience refractory or recurrent disease. The aim of this study was to evaluate the effectiveness of a single daily high dose probiotic preparation (VSL#3) in maintaining antibiotic induced remission, and quality of life (QOL), for one year in such...

Subject

Pouchitis

Medicine

Refractory (planetary science)

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!